WHO declares mpox a global health emergency
An outbreak of the viral disease formerly known as monkeypox continues to spread in Africa
What happened
The World Health Organization (WHO) declared an mpox outbreak in Africa a "public health emergency of international concern." The highly infectious strain of mpox, formerly called monkeypox, has jumped from the Democratic Republic of Congo (DRC) to a dozen other African countries.
Who said what
The spread and adaptability of this mpox strain is "very worrying," said WHO Director-General Tedros Adhanom Ghebreyesus. "A coordinated international response is needed to stop these outbreaks and save lives." The WHO last designated mpox a global emergency in 2022, when an outbreak affected nearly 100,000 people, "primarily gay and bisexual men, in 116 countries," The New York Times said. That outbreak killed about 200 people.
In the DRC, children make up "the majority of the 14,000 reported cases and 511 deaths so far" this year, NPR said. The global health emergency designation will unlock certain resources to help contain and neutralize this outbreak. But it's a "failure of the global community that things had to get this bad to release the resources needed," Michael Marks, a professor at the London School of Hygiene and Tropical Medicine, told The Associated Press.
What next?
Declaring mpox a global health emergency is "intended to prompt member countries to begin preparing for the virus' appearance and to share vaccines, treatments and other key resources with poorer nations," the Times said. The Centers for Disease Control and Prevention alerted American clinicians about the outbreak last week.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Rafi Schwartz has worked as a politics writer at The Week since 2022, where he covers elections, Congress and the White House. He was previously a contributing writer with Mic focusing largely on politics, a senior writer with Splinter News, a staff writer for Fusion's news lab, and the managing editor of Heeb Magazine, a Jewish life and culture publication. Rafi's work has appeared in Rolling Stone, GOOD and The Forward, among others.
-
The week's best photos
A helping hand, a rare dolphin and more
By Anahi Valenzuela, The Week US Published
-
Today's political cartoons - August 30, 2024
Cartoons Friday's cartoons - seasoned vets, football season, and more
By The Week US Published
-
'Harris gains slim lead'
Today's Newspapers A roundup of the headlines from the US front pages
By The Week Staff Published
-
Baby food is not as healthy as it should be
Under the Radar Labels are leaving things out. And brands are highlighting only what they want to.
By Devika Rao, The Week US Published
-
Should we be worried about declining birth rates?
Talking Points Baby boom or bust
By Devika Rao, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
The battle for abortion buffer zones
The Explainer A 2023 law banning protests around clinics remains unenforced amid dispute over 'silent prayer'
By Harriet Marsden, The Week UK Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
Why gonorrhoea is becoming 'untreatable'
In the Spotlight Infections hit record high as experts warn about rise in antibiotic-resistant cases
By Elizabeth Carr-Ellis, The Week UK Published
-
Where does MDMA-assisted therapy go from here?
Today's Big Question Psychedelic treatments face a challenge from the FDA
By Joel Mathis, The Week US Published
-
Can dementia be defeated?
Today's Big Question A new report identifies 14 risk factors
By Joel Mathis, The Week US Published